Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity

Quercioli, A.; Pataky, Zoltan; Vincenti, Gabriella; Makoundou, Vincent; Di Marzo, Vincenzo; Montecucco, Fabrizio; Carballo, Sebastian; Thomas, Aurélien; Staub, C.; Steffens, Sabine; Seimbille, Yann; Golay, A.; Ratib, Osman; Harsch, E.; Mach, François; H. Schindler, Thomas

doi:10.1093/eurheartj/ehr029

Public

Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity

Published in European Heart Journal • Feb 8, 2011

Authors:

A. Quercioli

Zoltan Pataky

Gabriella Vincenti

Abstract

AIMS: Aim of this study was to evaluate a possible association between endocannabinoid (EC) plasma levels, such as anandamide (AEA) and 2-arachidonoylglycerol (2-AG), and coronary circulatory function in obesity. METHODS AND RESULTS: Myocardial blood flow (MBF) responses to cold pressor test (CPT) a...

Subject

Medicine

Internal medicine

Anandamide

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!